Filaminast

DB02660ExperimentalSmall molecule

Filaminast is a phosphodiesterase 4 inhibitor (PDE4 inhibitor). As such, has potential in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Mechanism: Pharmacologically active on 3',5'-cyclic-AMP phosphodiesterase 4B
Curator reviewed
Formula / weight: C₁₅H₂₀N₂O₄ · 292.3303 g/mol (avg)
Code names: WAY-PDA-641

Resolves to

Compound

UNIICDD69JC61JCAS141184-34-1ChEMBLCHEMBL590754ChEBI697724PubChem9578243

Structure

InChIKeySTTRYQAGHGJXJJ-LICLKQGHSA-NSMILESCOC1=CC=C(C=C1OC1CCCC1)C(\C)=N\OC(N)=O

Targets

Q07343PDE4B

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Filaminast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account